Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Portal hypertensive bleeding.

Kevin M Comar1, Arun J Sanyal

  • 1Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University, MCV Box 980711, Sanger Hall 12011, Richmond, VA 23298-0711, USA.

Gastroenterology Clinics of North America
|December 31, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome.

Kidney360·2023
Same author

Reduced metabolic flexibility is a predictor of weight gain among liver transplant recipients.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2023
Same author

Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study.

Gastroenterology·2023
Same author

Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2023
Same author

Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2023
Same author

Noninvasive Assessment of Liver Fibrosis in NAFLD.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2023

Cirrhosis patients need endoscopy to assess bleeding risks from esophageal varices, gastric varices, or portal hypertensive gastropathy (PHG). Treatment involves beta-blockers, endoscopic variceal ligation (EVL), or other therapies to prevent and manage bleeding.

Area of Science:

  • Gastroenterology
  • Hepatology
  • Internal Medicine

Background:

  • Portal hypertension bleeding is a frequent and severe complication in cirrhosis patients.
  • Early evaluation for bleeding causes like varices and PHG is crucial for all cirrhosis patients.

Purpose of the Study:

  • To outline diagnostic and therapeutic strategies for portal hypertension bleeding in cirrhosis.
  • To emphasize the importance of risk stratification and tailored treatment approaches.

Main Methods:

  • Endoscopic evaluation for varices and PHG.
  • Pharmacologic therapy with nonselective beta-blockers for high-risk varices.
  • Hepatovenous pressure gradient (HVPG) measurements for monitoring therapy.
  • Endoscopic variceal ligation (EVL) for refractory cases.

Related Experiment Videos

  • Pharmacologic agents (terlipressin, somatostatin, octreotide) for acute bleeding.
  • Transjugular intrahepatic portosystemic shunt (TIPS) or surgery as salvage therapies.

    • Main Results:

    • Nonselective beta-blockers are recommended for primary prevention of variceal hemorrhage.
    • HVPG monitoring is optimal for assessing pharmacologic therapy success.
    • Acute bleeding management requires resuscitation, complication prevention, and bleeding control.
    • Terlipressin, somatostatin, or octreotide are indicated for acute esophageal variceal and PHG bleeding.
    • Gastric variceal bleeding treatment lacks a standardized optimal approach, requiring individualized plans.

    Conclusions:

    • Comprehensive endoscopic evaluation and risk assessment are fundamental for managing portal hypertension bleeding.
    • A multi-modal approach combining pharmacologic, endoscopic, and interventional therapies is necessary.
    • Individualized treatment strategies are essential, particularly for gastric variceal bleeding.